Tag: Novo Nordisk A/S

The biggest winners and losers in Europe as Trump announces sweeping tariffs

Zepbound copycats remain online despite FDA ban

FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound, caught up in East Coast trade shutdown

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

What’s next for the Biden administration’s Medicare drug price negotiations

Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says

Novo Nordisk’s Wegovy weight loss drug approved in China

Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet

Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that